Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX - Get Free Report)'s stock price shot up 1.4% during trading on Monday . The stock traded as high as $15.99 and last traded at $13.80. 5,478 shares traded hands during trading, a decline of 80% from the average session volume of 26,994 shares. The stock had previously closed at $13.61.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently weighed in on the stock. UBS Group boosted their price objective on shares of Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the company a "buy" rating in a report on Monday, January 27th. William Blair reiterated an "outperform" rating on shares of Telix Pharmaceuticals Limited American Depositary Shares in a research note on Wednesday, March 12th.
Check Out Our Latest Stock Report on Telix Pharmaceuticals Limited American Depositary Shares
Telix Pharmaceuticals Limited American Depositary Shares Stock Performance
The stock has a 50-day moving average of $17.36.
About Telix Pharmaceuticals Limited American Depositary Shares
(
Get Free Report)
Telix Pharmaceuticals Limited. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.
Featured Articles
Before you consider Telix Pharmaceuticals Limited American Depositary Shares, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Telix Pharmaceuticals Limited American Depositary Shares wasn't on the list.
While Telix Pharmaceuticals Limited American Depositary Shares currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
